The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma. (2022). Journal of Pharmaceutical Negative Results, 13(3), 20-25. https://doi.org/10.47750/pnr.2022.13.03.004